No Picture
Trading Ideas

Wynn Resorts CEO calls for Las Vegas Strip to conditionally reopen in mid- to late May

In an opinion column https://thenevadaindependent.com/article/a-plan-to-re-open-nevada published on the Nevada Independent news website, Maddox said Governor Steve Sisolak should reopen parts of the local economy in early May. Sisolak ordered all casinos and other nonessential businesses in the state to close for 30 days beginning March 18. In Nevada, there have been at least 3,725 people confirmed to have the coronavirus and 155 deaths. …read more […]

No Picture
Trading Ideas

Bulls And Bears Of The Week: Caterpillar, Facebook, Microsoft And More

Benzinga has examined the prospects for many investor favorite stocks over the past week. Bullish calls included e-commerce, software and social media leaders.Bearish calls included the iPhone maker and a top video streamer.The major U.S. indexes saw another gain for the week, led by the 6% rise in the Nasdaq. Big banks kicked off the first-quarter earnings reporting season, new jobless numbers remained ugly, the president pushed to restart the U.S. economy by reopening businesses and there were signs that things might be looking up for oil.Benzinga continues to examine the prospects for many of the stocks most popular with …read more […]

No Picture
Trading Ideas

'They're killing us,' Texas residents say of Trump rollbacks

Nelson suspects the towering plants and refineries are to blame, rising like a lit-up city at night around her squat brick apartment building in the rugged Texas Gulf Coast city of Port Arthur. Ask Nelson what protection the federal government and plant operators provide her African American community, and her answer is blunt. “They’re basically killing us,” says the 37-year-old, who herself has been diagnosed with respiratory problems since moving to the community after 2017′s Hurricane Harvey. …read more […]

No Picture
Business News

Stock market gains alongside economic pain; some worry about over-optimism

The U.S. stock market has rebounded swiftly despite a raft of terrible economic news, driven by a massive boost from the Federal Reserve, hopes of a successful reopening of the economy and possible coronavirus treatments, as well as investors’ fear-of-missing-out. But not everyone is buying the bounce.

…read more […]

No Picture
Trading Ideas

Stock market gains alongside economic pain; some worry about over-optimism

Investors and analysts have turned more positive. Goldman Sachs last week said the unprecedented monetary and fiscal policy actions by the Fed and Congress had “precluded the prospect of a complete economic collapse,” meaning its previous near-term downside forecast for the S&P of 2000 was no longer likely. …read more […]

No Picture
Trading Ideas

3 Cannabis Stocks to Buy for a Strong March Quarter

The cannabis sector got a big boost in the last few weeks as governments around Canada and the U.S. confirmed most cannabis stores as essential. While most stores are closing outside of grocery stores, cannabis dispensaries were deemed essential due to their medical cannabis component.Despite early indications of strong demand for cannabis, most of the stocks trade near the recent multi-year lows due to fears the coronavirus outbreak eventually does damage demand. Already, some states are seeing the initial surges in demand wane as businesses were deemed essential, thereby reducing the need to rush into stores during this crisis. Consumers …read more […]

No Picture
Trading Ideas

Incyte, Novartis Initiate Phase 3 Jakavi Drug Study For Coronavirus Treatment

Global biotech company Incyte (INCY) announced on Friday that it has initiated a Phase 3 clinical trial in collaboration with Novartis (NVS) to test the potential of its Jakavi drug in patients infected with the coronavirus-caused COVID-19.Jakavi is used in adults with bone marrow cancer, or myelofibrosis, among other conditions. Incyte and Novartis seek to evaluate if the drug helps COVID-19 patients suffering from an immune system overreaction, also called a cytokine storm, which could result in complications like pneumonia or acute respiratory distress syndrome. The Phase 3 study will compromise about 400 patients globally. The collaborative study will be …read more […]